Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 5, 1997

View Archived Issues

MRI image-enhancing agents claimed by Nycomed Imaging

HMR describes new cognition-enhancing agents

NES-1 polypeptides reported for carcinoma detection and treatment

Analogues of botulinum toxin discovered with longer half-life

Bone morphogenic protein-10 claimed by Human Genome Sciences

Pineal gland-specific gene-1 disclosed by HGS

Takeda discloses novel cephems

Merck & Co. pursues alpha1a-adrenoceptor antagonists for BPH

PDE IV/TNF production inhibitors claimed by Pfizer

Tanabe synthesizes ET antagonists

Company Profile: NicOx S.A.

IL-6 antagonists from Daicel

AMDL launches new line of diagnostics

Pierre Fabre antidepressant approved in France

Nortran completes trials in volunteers with antiarrhythmic

Myriad strengthens proprietary position for diagnostic for salt-dependent hypertension

Hyal's Solarase submitted for approval

New use of ciclosporin recommended for approval

ChiRex and Cell Therapeutics sign supply agreement

SmithKline Beecham Lyme disease vaccine update

CF gene therapy product enters phase II

American Biogenetic Sciences seeks FDA approval for diagnostic test

FDA panel to review Carticel service

COR Therapeutics' cardiovascular drug candidate enters phase I trials

Impotence Rx expected to enter phase II this year

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...